Co-hosted by the Indo US Organization for Rare Diseases and George Mason University, the 2025 Indo US Bridging RARE Summit will focus on “Strengthening the Framework for Inclusive and Accessible Patient-Focused Clinical Research in Rare Diseases.”
This three-day hybrid event will feature expert speakers from medicine, science, regulatory agencies, patient advocacy, and industry. Highlights include the Pitch4Rare startup pitch contest, workshops, and a Gala Dinner and Award Ceremony honoring distinguished leaders with the Abbey Meyers Khushi Bridging RARE Award.
The Summit is designed to encourage global collaboration, particularly between India and the U.S., to advance patient-centered drug development for rare diseases. Sessions will be live-streamed, with recordings made available online following the event.